RE:RE:RE:RE:Immunity bio doing well Immunity Bio`s results are impressive but treatment looks to involve 2 x series of 6 instillations (including BCG) plus 3-year maintenance? In contrast and where TLT could really shine is through the reduction of an overwhelming and increasing workload in Public Health and beyond.
Imagine only 2 x outpatient treatments (six months apart) for refractory NMIBC? - or (thanks for the heads up Dawg) those given a diagnosis of later stage lung cancer booked in for a jab and an x-ray (with or without adjuvants)?
It is injectable Rutherrin (we are told here currently under development) that will take TLT to the next level with such treatments - the sooner it arrives the better for all.